Symbol
Anika Therapeutics Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$9.02
Current price of the stock
$112K
Trading volume of the stock
$130.9M
Market capitalization of the company
Micro Cap
Category of market capitalization
10.00%
Long-term growth mean estimate
4.50
Mean analyst rating
103.25%
Potential price appreciation based on analyst price targets
2.94%
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
6.18
Current ratio
50.90%
Gross profit margin
-14.81%
Operating profit margin
-14.81%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-14.05%
Pretax profit margin
-14.07%
Net profit margin
-3.15%
Measures profitability relative to shareholders' equity
-3.37%
ROE excluding intangible assets
-2.48%
Measures profitability relative to total assets
-3.15%
Measures profitability relative to invested capital
0.15
Asset turnover ratio
0.82
Inventory turnover ratio
1.18
Receivables turnover ratio
76.40
Average number of days it takes to collect receivables
-2.18
Measures valuation relative to earnings
-11.00
P/E based on future earnings estimates
1.14
Measures valuation relative to sales
0.88
Measures valuation relative to book value
15.17
Measures valuation relative to operating cash flow
-11.03
Measures valuation relative to free cash flow
8
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
